← FDA DRUG APPROVALS

FDA ANDA · ANDA040516

CHLOROQUINE PHOSPHATE

Sponsor: IMPAX LABS

APPLICATION
ANDA040516
TYPE
ANDA
ORIGINAL APPROVAL
2003-08-29
LATEST ACTION
2023-07-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

CHLOROQUINE PHOSPHATEPrescription
CHLOROQUINE PHOSPHATE 500MG · TABLET · ORAL

Approval history

2023-07-24Labeling · Supplement 16 · standardAP
2022-05-03Labeling · Supplement 14 · standardAP
2022-03-16Labeling · Supplement 13 · standardAP
2020-04-28Labeling · Supplement 11 · standardAP
2003-08-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →